In vitro and in vivo effects of naringin on cytochrome P450-dependent monooxygenase in mouse liver

Life Sciences

Volumn 65, Issue 24, 1999, Pages 2591-2602

  Ueng, Yune Fang ^a   Chang, Yuh Lih ^d,e   Oda, Yoshimitsu ^b   Park, Sang S ^c   Liao, Jyh Fei ^e   Lin, Min Fang ^d   Chen, Chieh Fu ^a  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^b Osaka City Inst of Public Health   (Japan)

^c Korea Occupational Safety and Health Agency   (South Korea)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cytochrome P450; Genotoxicity; Naringenin; Naringin

Indexed keywords

AURANTIIN; BENZO[A]PYRENE; BETA GALACTOSIDASE; CYTOCHROME P450; EDRECOLOMAB; NARINGENIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GENE EXPRESSION; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER METABOLISM; LIVER MICROSOME; MALE; MOUSE; NONHUMAN;

EID: 0033527677     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00528-7     Document Type: Article

References (46)

1. A.Y.H. Lu and S.B. West, Pharmacol. Rev. 31 277-295 (1980).
2. F.P. Guengerich, Cancer Res. 48 2946-2954 (1988).
3. D.W. Nebert, Crit. Rev. Toxicol. 20 153-174 (1989).
4. F.P. Guengerich and T. Shimada, Chem. Res. Toxicol. 4 391-407 (1991).
5. M.G.L. Hertog, P.C.H. Hollman, M.B. Katan and D. Kromhout, Nutr. Cancer 20 21-29 (1993).
6. P. Knekt, R. Järvinen, R. Seppänen, M. Heliövaara, L. Teppo, E. Pukkala and A. Aromaa, Am. J. Epidemiol. 146 223-230 (1997).
7. P.C.H. Hollman, M.G.L. Hertog and M.B. Katan, Biochem. Soc. Trans. 24 785-789 (1996).
8. A. Das, J.H. Wang And E.J. Lien, Progress Drug. Res. 42 133-166 (1994).
9. S.C. Sahu, Environ. Carcino. Ecotox. Revs. C12 1-21 (1994).
10. B. Ameer and R.A. Weintraub, Clin. Pharmacokinet. 33 103-121 (1997).
11. D.G. Bailey, O.M. Arnold, C. Munoz, and J.D. Spence, Clin. Pharmacol. Ther. 53 637-642 (1993).
12. K. Fukuda, T. Ohta And Y. Yamazoe, Biol. Pharm. Bull. 20 560-564 (1997).
13. U. Fuhr, Drug Safety 18 251-272 (1998).
14. U. Fuhr, K. Klittich and A.H. Staib, Br. J. Clin. Pharmacol. 35 431-436 (1993).
15. W.A. Maish, E.M. Hampton, T.L. Whitsett, J.D. Shepard and W.R. Lovallo, Pharmacotherapy 16 1046-1052 (1996).
16. F.V. So, N. Guthrie, A.F. Chambers, M. Moussa and K.K. Carroll, Nutr. Cancer 26 167-181 (1996).
17. F.P. Guengerich and D.H. Kim, Carcinogenesis 11 2275-2279 (1990).
18. M.K. Buening, R.L. Chang, M.T. Huang, J.G. Fortner, A.W. Wood and A.H. Conney, Cancer Res. 41 67-72 (1981).
19. I.B. Tsyrlov, V.M. Mikhailenko and H.V. Gelboin, Biochim. Biophys. Acta 1205 325-335 (1994).
20. C.S. Lieber and L.M. Decarli, Alcohol Clin. Exp. Res. 10 550-553 (1986).
21. T.H. Ueng, Y.F. Ueng, T.L. Chen, S.S. Park, M. Iwasaki and F.P. Guengerich, Toxicol. Appl. Pharmacol. 119 66-73 (1993).
22. Y. Oda, S.I. Nakamura, I. Oki, T. Kato and H. Shinagawa, Mutat. Res. 147 219-229 (1985).
23. T. Shimada, Y. Oda, H. Yamazaki, M. Mimura and F.P. Guengerich, Methods in molecular genetics vol. 5, Gene and Chromosome Analysis, K.W. Adolph (Ed.), 342-355. Academic Press, Orlando, FL (1994).
24. T. Omura and R. Sato, J. Biol. Chem. 239 2370-2379 (1964).
25. A.H. Phillips and R.G. Langdon, J. Biol. Chem. 237 2652-2660 (1962).
26. D.W. Nebert and H.V. Gelboin, J. Biol. Chem. 243 6242-6249 (1968).
27. R.J. Pohl and J.R. Fouts, Anal. Biochem. 107 150-155 (1980).
28. W.F. Greenlee and A. Poland, J. Pharmacol. Exp. Ther., 205 596-605 (1978).
29. F.P. Guengerich, M.V. Martin, P.H. Beaune, P. Kremers, T. Wolff and D.J. Waxman, J. Biol. Chem. 261 5051-5060 (1986).
30. W.R. Brian, M.A. Sari, M. Iwasaki, T. Shimada, L.S. Kaminsky and F.P. Guengerich, Biochemistry 29 11280-11292 (1990).
31. T. Nash, Biochem. J. 55 416-421 (1953).
32. O.H. Lowry, N.J. Roseborough, A.L. Farr and R.L Randall, J. Biol. Chem. 193 265-275 (1951).
33. U.K. Laemmli, Nature 227 680-685 (1970).
34. H. Towbin, T. Staehelin and J. Gordon, Proc. Natl. Acad. Sci. USA 76 4350-4354 (1979).
35. C. Heidelberger, Annu. Rev. Biochem. 44 79-121 (1975).
36. M.T. Huang, A.W. Wood, H.L. Newmark, J.M. Sayer, H. Yagi, D.M. Jerina and A.H. Conney, Carcinogenesis 4 1631-1637 (1983).
37. J.Y. Moon, D.W. Lee and K.H. Park, Xenobiotica 28 117-126 (1998).
38. M.T. Obermeier, R.E. White and C.S. Yang, Xenobiotica 25 575-584 (1995).
39. E Bauer, Z. Guo, Y.F. Ueng, L.C. Bell, D. Zeldin and F.P. Guengerich, Chem. Res. Toxicol. 8 136-142 (1995).
40. F.P. Guengerich, Cytochrome P450, Ortiz de Montellano PR (Ed.), 473-535, Plenum Press, New York and London (1995).
41. M. Negishi, N.M. Jensen, G.S. Garcia and D.W. Nebert, Eur. J. Biochem. 115 585-594 (1981).
42. P.V. Nerurkar, S.S. Park, P.E. Thomas, R.W. Nims and R.A. Lubert, Biochem. Pharmacol. 46 933-943 (1993).
43. K.S. Lown, D.G. Bailey, R.J. Fontana, S.K. Janardan, C.H. Adair, L.A. Fortlage, M.B. Brown, W. Guo and P.B. Watkins, J. Clin. Invest. 99 2545-2553 (1997).
44. K. Wakabayashi, M. Nagao, H. Esumi and T. Sugimura, Cancer Res. 52 2092s-2098s (1992).
45. U. Fuhr and A.L. Kummert, Clin. Pharmacol. Ther. 58 365-373 (1995).
46. P.C.H. Hollman, J.H.M. De Vries, S.D. Van Leeuwen, M.J.B. Mengelers and M.B. Katan, Am. J. Clin. Nutr.62 1276-1282 (1995).